106
Views
4
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Treatment of depressive symptoms and attitudes towards treatment options in a representative German general population sample

, , &
Pages 5-10 | Received 23 Aug 2006, Published online: 12 Jul 2009

References

  • Merry S, McDowell H, Hetrick S, Bir J, Muller N. Psychological and/or educational interventions for the prevention of depression in children and adolescents. Cochrane Database Syst Rev 2006;3.
  • Furukawa T, Streiner D, Young LY. V. Antidepressant and benzodiazepine for major depression. Cochrane Database Syst Rev 2006;3.
  • Williams JW, Jr, Mulrow CD, Chiquette E, Noel PH, Aguilar C, Cornell J. A systematic review of newer pharmacotherapies for depression in adults: evidence report summary. Ann Intern Med 2000; 132: 743–56
  • Ballenger JC, Davidson JR, Lecrubier Y, et al. Consensus statement on the primary care management of depression from the International Consensus Group on Depression and Anxiety. J Clin Psychiatry 1999; 60: 54–61
  • Wittchen HU, Müller N, Schmidtkunz B, Winter S, Pfister H. [Manifestation, prevalence and management of depression. Results of the nationwide survey “Mental Disorders”]. [German]. Fortschr Med 2000; S1: 4–9
  • Wittchen HU, Winter S, Höfler M, et al. [Prevalence and recognition of depression in the general practice]. [German]. Fortschr Med 2000; S1: 22–30
  • Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994; 51: 8–19
  • Wittchen HU, Knauper B, Kessler RC. Lifetime risk of depression. Br J Psychiatry Suppl 1994; 26: 16–22
  • Murray CJ, Lopez AD. The Global Burden of Disease: a Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020. World Health Organization, Geneva 1996
  • Angermeyer MC, Dietrich S. Public beliefs about and attitudes towards people with mental illness: a review of population studies. Acta Psychiatr Scand 2006; 113: 163–79
  • McKeon P, Gavigan P, Carrick S. Aware of depression ten years on: The irish perspective. Int J Methods Psychiatr Res 1996; 6: S3–S8
  • Peveler R, Kendrick T. Treatment delivery and guidelines in primary care. Br Med J 2001; 57: 193–206
  • Kroll M, Dietrich S, Angermeyer MC. [The presentation of depression in German daily newspapers. A trend analysis]. [German]. Psychiatr Prax 2003; 30: 367–71
  • Deutsche Gesellschaft für Psychiatrie PuND. [Practice Guidelines in Psychiatry and Psychotherapy: Treatment Guideline Affective Disorders]. [German]. Darmstadt: Steinkopff; 2000.
  • American Psychiatric Association (APA). Practice Guidelines for the Treatment of Major Depressive Disorders. Washington, DC: American Psychiatric Association; 2000
  • Crismon ML, Trivedi M, Pigott TA, et al. V: The Texas Medication Algorithm Project: report of the Texas Consensus Conference Panel on medication treatment of major depressive disorder. J Clin Psychiatry 1999; 60: 142–56
  • Depression Guideline Panel. Depression in primary care: Volume 1, Detection and diagnosis. Clinical practice guideline, Number 5. Rockville, MD: US Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research; 1993.
  • Katon W, Von Korff M, Lin E, et al. Collaborative management to achieve treatment guidelines. Impact on depression in primary care. J Am Med Assoc 1995; 273: 1026–31
  • Paykel ES, Tylee A, Wright A, Priest RG, Rix S, Hart D. The defeat depression campaign: psychiatry in the public arena. Am J Psychiatry 1997; 154: 59–65
  • Lin EH, Katon WJ, Simon GE, et al. Achieving guidelines for the treatment of depression in primary care: is physician education enough?. Med Care 1997; 35: 831–42
  • Schulberg HC, Katon WJ, Simon GE, Rush AJ. Best clinical practice: guidelines for managing major depression in primary medical care. J Clin Psychiatry 1999; 60: 19–26
  • Finley PR, Rens HR, Pont JT, et al. V: Impact of a collaborative care model on depression in a primary care setting: A randomized, controlled trial. Pharmacotherapy 2003; 23: 1175–85
  • Haerter M, Bermejo I, Niebling W, Schneider F, Berger M. [Networked care of depressive patients – development of a treatment corridor and implementation of evidence-based recommendations]. [German]. Z Allgemeinmed 2003; 78: 231–8
  • Kendrick T. Why can't GPs follow guidelines on depression?. Br Med J 2000; 320: 200–1
  • Gilbody S, Whitty P, Grimshaw J, Thomas R. Educational and organizational interventions to improve the management of depression in primary care: a systematic review. J Am Med Assoc 2003; 289: 3145–51
  • Oldehinkel AJ, Wittchen HU, Schuster P. Prevalence, 20-month incidence and outcome of unipolar depressive disorders in a community sample of adolescents. Psychol Med 1999; 29: 655–68
  • Angermeyer MC, Matschinger M, Riedel-Heller SG. Whom to ask for help in case of a mental disorder? Preferences of the lay public. Soc Psychiatry Psychiatr Epidemiol 1999; 34: 202–10
  • Priest RG, Vize C, Roberts A, Roberts M, Tylee A. Lay people's attitudes to treatment of depression: results of opinion poll for Defeat Depression Campaign just before its launch. Br Med J 1996; 313: 858–9
  • Wernicke TF, Linden M. Clinical recognition and drug treatment of depression in cases found by standardized assessment. Pharmacopsychiatry 1994; 27: 54–7
  • Hegerl U, Althaus D, Stefanek J. Public attitudes towards treatment of depression: effects of an information campaign. Pharmacopsychiatry 2003; 36: 288–91
  • Degner D, Grohmann R, Kropp S, et al. Severe adverse drug reactions of antidepressants: results of the German multicenter drug surveillance program AMSP. Pharmacopsychiatry 2004; 37(S1)S39–S45
  • Donoghue JM, Tylee A. V: The treatment of depression: prescribing patterns of antidepressants in primary care in the UK. Br J Psychiatry 1996; 168: 164–8
  • Angermeyer MC, Matschinger M. Lay beliefs about mental disorders: a comparison between the western and the eastern parts of Germany. Soc Psychiatry Psychiatr Epidemiol 1999; 34: 275–81
  • Harrison P. Herbal medicine takes root in Germany. Can Med Assoc J 1998; 158: 637–9
  • Katon W, Robinson P, VonKorff M, et al. A multifaced intervention to improve treatment of depression in primary care. Arch Gen Psychiatry 1996; 53: 924–32
  • Kasper S. Hypericum perforatum – a review of clinical studies. Pharmacopsychiatry 2001; 34(S1)S51–S55
  • Linde K, Berner M, Egger M, Mulrow C. St John's wort for depression: meta-analysis of randomised controlled trials. Br J Psychiatry 2005; 186: 99–107
  • Wurglics M, Schubert-Zsilavecz M. [Charge conformity and biopharmaceutic characterization. St. John's Wort extract preparations in comparison]. [German]. Pharm Unserer Zeit 2003; 32: 236–41
  • Wurglics M, Westerhoff K, Kaunzinger A, et al. Comparison of German St. John's wort products according to hyperforin and total hypericin content. J Am Pharm Assoc (Washington) 2001; 41: 560–6
  • Wurglics M, Westerhoff K, Kaunzinger A, Wilke A, Baumeister A, Dressman J, et al. Batch-to-batch reproducibility of St. John's wort preparations. Pharmacopsychiatry 2001; 34(S1)S152–S156
  • Walsh BT, Seidman SN, Sysko R, Gould M. Placebo response in studies of major depression: variable, substantial, and growing. J Am Med Assoc 2002; 287: 1840–7
  • Scogin FR, Hanson A, Welsh D. Self-administered treatment in stepped-care models of depression treatment. J Clin Psychol 2003; 59: 341–9

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.